Monash IVF Group Limited
Monash IVF Group Limited
- P/E ratio
- 38.74
Your view on MVF.AX
Overview
What the company does, where it operates, and who runs it.
About Monash IVF Group Limited
- Industry
- Medical - Diagnostics & Research
- Sector
- Healthcare
- CEO
- Victoria Atkinson Afracma Fracs Mbbs
- Headquarters
- Pelaco Building 1, Richmond, VIC, AU
- Industry
- Medical - Diagnostics & Research
- Sector
- Healthcare
- CEO
- Victoria Atkinson Afracma Fracs Mbbs
- Headquarters
- Pelaco Building 1, Richmond, VIC, AU
Founded in 2014 and headquartered in Richmond, Australia, Monash IVF Group Limited delivers specialized reproductive assistance and women's imaging services. Its operations span Australia and Malaysia, offering a broad spectrum of care.
This includes diagnostic obstetric and gynecological ultrasound examinations, a range of fertility treatments, and advanced tertiary-level prenatal diagnostics. The company is also a key provider of in-vitro fertilization (IVF) services.
Stock Data
Price chart, volume, and trading data.
FRC Fair Value Algorithm
What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.
About this section
Fair value for Monash IVF Group Limited from FRC's valuation model, read against the market price. MVF.AX last traded at AUD 0.69, 38.7× trailing earnings — the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for Monash IVF Group Limited. Starting points for Monash IVF Group Limited: P/E 38.7, EPS AUD 0.02, beta 0.38 — an Medical - Diagnostics & Research name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for Monash IVF Group Limited. Monash IVF Group Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for Monash IVF Group Limited. Trailing twelve-month EPS for Monash IVF Group Limited stands at AUD 0.02. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Wall Street Analyst Estimates
Analysts' price targets, ratings, and revenue and EPS estimates.
Earnings per share estimates
| Per share | This quarterSep 2025 | Next quarterDec 2025 | This yearYear to Jun 2027 | Next yearYear to Jun 2028 |
|---|---|---|---|---|
| Average estimate | AUD 0.00 | AUD 0.03 | AUD 0.05 | AUD 0.05 |
| Lowest estimate | AUD 0.00 | AUD 0.03 | AUD 0.04 | AUD 0.05 |
| Highest estimate | AUD 0.00 | AUD 0.03 | AUD 0.05 | AUD 0.06 |
| Number of analysts | 0 | 1 | 5 | 5 |
| A year ago | AUD 0.02 | AUD 0.03 | AUD 0.021 | — |
| Growth vs a year ago | −100.0% | −22.8% | — | — |
1The year-ago figure includes one-time items, so growth is not shown.
Revenue estimates
| Total | This quarterSep 2025 | Next quarterDec 2025 | This yearYear to Jun 2027 | Next yearYear to Jun 2028 |
|---|---|---|---|---|
| Average estimate | AUD 134.84M | AUD 127.47M | AUD 280.80M | AUD 293.62M |
| Lowest estimate | AUD 134.84M | AUD 127.47M | AUD 275.97M | AUD 283.72M |
| Highest estimate | AUD 134.84M | AUD 127.47M | AUD 284.93M | AUD 301.31M |
| Number of analysts | 2 | 1 | 7 | 7 |
| A year ago | AUD 91.32M | AUD 110.27M | AUD 269.46M | — |
| Growth vs a year ago | +47.7% | +15.6% | +4.2% | — |
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for Monash IVF Group Limited. Monash IVF Group Limited has reported as a listed company since 2014. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Industry | |
|---|---|---|---|---|---|
| ACL.AXAustralian Clinical Labs Limited | Healthcare | Medical - Diagnostics & Research | — | ||
| BDX.AXBCAL Diagnostics Limited | Healthcare | Medical - Diagnostics & Research | — | ||
| GSS.AXGenetic Signatures Limited | Healthcare | Medical - Diagnostics & Research | — | ||
| HLS.AXHealius Limited | Healthcare | Medical - Diagnostics & Research | — | ||
| HMD.AXHeraMED Limited | Healthcare | Medical - Devices | — | ||
| IDX.AXIntegral Diagnostics Limited | Healthcare | Medical - Diagnostics & Research | — | ||
| IIQ.AXINOVIQ Ltd | Healthcare | Medical - Diagnostics & Research | — | ||
| IME.AXImExHS Limited | Healthcare | Medical - Diagnostics & Research | — | ||
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| WGSGeneDx Holdings Corp. | Healthcare | NASDAQ | $1.6B | ||
| WUXAYWuXi AppTec Co., Ltd. | Healthcare | OTC | $45.6B | ||
| WUXIFWuXi AppTec Co., Ltd. | Healthcare | OTC | $39.8B | ||
| XGNExagen Inc. | Healthcare | NASDAQ | $99.5M | ||
| SKHHYSonic Healthcare Limited | Healthcare | OTC | $8.2B | ||
| SLDXStella Diagnostics Inc. | Healthcare | OTC | $1.4M | ||
| SPDESpeedus Corp. | Healthcare | OTC | $416 | ||
| SZLSFStageZero Life Sciences Ltd. | Healthcare | OTC | $61,766 | ||
| TDSGFTelo Genomics Corp. | Healthcare | OTC | $3.8M | ||
| TELO.VTelo Genomics Corp. | Healthcare | TSXV | $4.0M | ||
| THOXFBioPorto A/S | Healthcare | OTC | $73.8M | ||
| TMOThermo Fisher Scientific Inc. | Healthcare | NYSE | $256.7B | ||
| Ticker | Fund | Fund assets | % of the fund |
|---|---|---|---|
| DISVDimensional - International Small Cap Value ETF | $5.1B in assets | 0.01% | |
| GWXState Street SPDR S&P International Small Cap ETF | $882M in assets | 0.03% | |
| DFISDimensional - International Small Cap ETF | $5.8B in assets | 0.00% | |
| DFAXDimensional - World ex US Core Equity 2 ETF | $11.7B in assets | 0.00% | |
| DFICDimensional - International Core Equity 2 ETF | $15.4B in assets | 0.00% | |
Largest holders first, then the funds most concentrated in MVF.AX.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Monash IVF Group Limited.